跳至主要内容
临床试验/ACTRN12620000487910
ACTRN12620000487910已完成未知

Retrospective and prospective study evaluating the sensitivity of upper respiratory swabs for SARS-CoV-2(COVID-19) NAT by determining the prevalence of SARS-CoV-2 antibody seroconversion following an initial negative swab in participants that have presented to the COVID-19 clinic

Albury Wodonga Health0 个研究点目标入组 103 人开始时间: 2020年4月20日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
103

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • Participants aged 18 years or over
  • Participants who have attended Albury-Wodonga Health Coronavirus Screening clinic and have had a NP swab collected for SARS-CoV-2 NAT
  • .• Both participants that have returned a negative or a positive swab will be included in the study.
  • Participants must be accessible for follow up testing
  • Able to read, write and understand English Participant Information and Consent Form
  • Signed Participant Information and Consent Form

排除标准

  • Participants under 18 years of age
  • Unwilling to be contacted for follow up testing
  • Medical or psychiatric condition or occupational responsibilities that may preclude compliance with the protocol
  • Research study personnel as identified in this Protocol

研究者

相似试验

Study evaluating Coronavirus (COVID-19) nasal/oral... | 临床试验